SRPT:NASDAQ
Sarepta Therapeutics Inc
US$ १७.८५
arrow_downward
-१.९८%(-०.३६) 1D
US$ १७.९५
arrow_upward
+०.५६% (+०.१०)bedtimeAfter hours
Closed: अक्टोबर ९, १६:००:०० GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SRPT...
Open
US$ १८.२४
High
US$ १८.५२
Low
US$ १७.६८
Mkt. cap
१.८९ अरब
Avg. vol.
३०.९१ लाख
Volume
३०.१५ लाख
52-wk high
US$ २४.६८
52-wk low
US$ १४.६९
EPS
-US$ १.६६
Beta
०.३८
Shares outstanding
१०.५६ करोड
No. of employees
८३५
Open
US$ १८.२४
High
US$ १८.५२
Low
US$ १७.६८
Mkt. cap
१.८९ अरब
Avg. vol.
३०.९१ लाख
Volume
३०.१५ लाख
52-wk high
US$ २४.६८
52-wk low
US$ १४.६९
EPS
-US$ १.६६
Beta
०.३८
Shares outstanding
१०.५६ करोड
No. of employees
८३५
News stories
From web sources and news partners
Stock Traders Daily
·
१ दिन पहिले
(SRPT) Risk Channels and Responsive Allocation
GuruFocus
·
२ दिन पहिले
SRPT Maintained by RBC Capital -- Price Target Lowered to $17.00
Profile
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
About Sarepta Therapeutics Inc